Default company panoramic image
Logo

Elute, Inc.

Drug-releasing bone void fillers that prevent orthopedic infection and promote bone healing.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Salt Lake City, UT, USA
  • Currency USD
  • Founded October 2011
  • Employees 7
  • Website elutinc.com

Company Summary

Elute, is focused on developing bone void fillers that combine well-known osteoconductive biomaterials bound together with degradable polymers and combined with tobramycin to form bone void filler devices for growing new bone in difficult-to-treat, persistent deep-bone infections in orthopedic surgery.
We just won fast-track 510(k) clearance for our first product and are discussing with the FDA a deNovo fast-track approval for its industry-first antibiotic eluting bone void filler.

Team

  • Default avatar
    David W. Grainger, PhD
    Chief Scientific Officer & Board of Directors

    Chair Bioengineering Dept. University of Utah. Scientific Advisor AO Foundation & Synthes.

  • Default avatar
    Dennis B. Farrar
    Chairman, Board of Directors

    Founding partner fo UpStart Ventures in Salt Lake City, Utah. Cofounder fo 13 life sciences companies, including Myriad Genetics (MYGN) and SerePrognostics (www.seraprognostics.com). He also cofounded Utah Ventures, Utah's first institutionally-financed venture fund. Mr. Farrar is a graduate of Stanford University and Stanford Law School and has practiced law with large firms in New York, San Francisco and Salt Lake City.

  • Default avatar
    Cheryl R. Blanchard, PhD
    Board of Directors

    20+ years of experience with orthopedic device companies.
    Former Chief Science Officer and Sr. Vice President of Zimmer Holdings (world's largest orthopedic company). Currently, CEO of BioCHIPS.

  • Default avatar
    Ashok C Khandkar
    CEO

    Ashok Khandkar joined the Company’s Board of Directors in December 2011 and serves as the CEO. He was the founding CEO of Amedica (Nasdaq, AMDA), an orthopedic company, from '00 - '09. In 2010, he founded Bloxr, (sold in Sept. 2014). He consults with a startup focused on a novel laparoscopy platform. He has over 27 years of experience in founding and leading companies. He earned his Ph.D. in Materials Science from Arizona State University.

  • Default avatar
    Jon Serbousek
    Board of Directors

    Jon joined the Company’s Board in August 2016. He held several senior management positions at Biomet, Inc. (now Zimmer Biomet) including SVP of Biomet, President of U.S. Orthopedics, Worldwide Group President of Orthopedics, and Worldwide President of Biomet Biologics. At Biomet, he oversaw products for the orthopedic, orthopedic reconstructive, biologic, trauma, and extremities with P&L responsibility for billion dollar enterprises.

Advisors

  • Default avatar
    Bruce Sunstein, Esq., Sunstein Kann Murphy & Timbers, Boston
    Lawyer
    Unconfirmed
    4f8484e4 efb1 44e6 b1c6 5d47780a0845
    Biostatistician
    Default avatar
    Don Urbanowicz
    Consultant
    Unconfirmed

Previous Investors

  • Default avatar
    UpStart Ventures
    Unconfirmed
    Default avatar
    JIS Ventures
    Unconfirmed
    Default avatar
    University of Utah Research Foundation
    Unconfirmed